NCT06275399

Brief Summary

The main objective of the present study is to verify, in vivo, whether shear forces computed solely based on coronary angiography and computational fluid dynamics (CFD) techniques are associated with the biomarkers indicating the prothrombotic tendency of circulating blood in situ - distally and proximally to the coronary stenosis. The study will prospectively assess the relationship between i) the value and distribution of shear rate and shear stress (SS) estimated using three-dimensional angiography and CFD techniques, and ii) atherosclerotic plaque characteristics as assessed by optical coherence tomography (OCT), iii) functional parameters of diseased vessels assessed by vessel fractional flow reserve (vFFR), and iv) in situ platelet activation, as expressed by platelet-derived microvesicles (pMVs) and small extracellular vesicles (sEVs), platelet aggregometry and other serum prothrombotic or inflammatory biomarkers sampled within the coronary artery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2023Jul 2026

Study Start

First participant enrolled

July 21, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 7, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2026

Expected
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

2 years

First QC Date

February 7, 2024

Last Update Submit

February 16, 2024

Conditions

Keywords

Optical Coherence TomographyvFFRShear RateImpedance aggregometryShear stressProteomicMetabolomicComputational fluid dynamicsProthrombotic plateletVulnerable plaque

Outcome Measures

Primary Outcomes (1)

  • Correlation between the mean shear rate and shear stress values at the lesion's site and the concentration of pMVs and sEVs sampled in the distal segment of the artery.

    Baseline

Secondary Outcomes (14)

  • Correlation between the shear stress measurements at the site of the lesion and the concentration of inflammatory biomarkers in the distal segment of the artery

    Baseline

  • Correlation between the shear stress measurements at the site of the lesion and the platelet reactivity parameters in the distal segment of the artery

    Baseline

  • Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) concentration of the pMVs and sEVs

    Baseline

  • Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) concentration of inflammatory biomarkers

    Baseline

  • Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) of platelet reactivity

    Baseline

  • +9 more secondary outcomes

Study Arms (1)

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging. The groups will be assessed at the time of angiography with: * OCT for evaluation of plaque morphology within the coronary stenosis * Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress * Impedance aggregometry based platelet reactivity * Single-particle high-resolution flow cytometry analysis of pMVs and sEVs as well as additional platelet activation and inflammatory biomarkers * Proteomic and metabolomic characterization - in the subset of patients Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment) arteries. Shear rate/shear stress distribution and biomarkers profile will be compared between the stenotic vessel and the non-stenotic vessel (stenoses \<30%) in the same patient.

Diagnostic Test: OCT examinationDiagnostic Test: Blood samplingDiagnostic Test: Assessment of vFFR and shear stress parameters

Interventions

OCT examinationDIAGNOSTIC_TEST

OCT examination for precise evaluation of plaque morphology within the coronary stenosis.

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging
Blood samplingDIAGNOSTIC_TEST

Blood sampling directly from coronary artery (proximal and distal segment) arteries

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging

The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients will be enrolled presenting with chronic coronary syndrome and angiographically confirmed coronary stenosis (30% - 90%) amenable to OCT imaging (according to the operator's judgment).

You may qualify if:

  • Chronic coronary syndrome
  • Angiographically confirmed coronary stenosis (30% - 90%)
  • Amenable to OCT imaging

You may not qualify if:

  • Cardiogenic shock
  • ST-segment elevation or non-ST-segment elevation myocardial infarction
  • Active bleeding
  • Left main coronary artery disease
  • Multivessel disease
  • Lesions located at a distance ≤3 mm from the ostium of the vessel
  • Thrombocytopenia
  • Previous coronary artery bypass grafting
  • Previous coronary intervention with stent implantation or balloon angioplasty
  • Previous use of novel oral anticoagulants or vitamin K antagonists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Warsaw

Warsaw, Masovian Voivodeship, 02-097, Poland

RECRUITING

MeSH Terms

Conditions

Atherosclerosis

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Adrian Bednarek

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Tomaniak Mariusz MD PhD Assoc. Prof.

Study Record Dates

First Submitted

February 7, 2024

First Posted

February 23, 2024

Study Start

July 21, 2023

Primary Completion

July 21, 2025

Study Completion (Estimated)

July 21, 2026

Last Updated

February 23, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations